SK5072003A3 - Polysubstituted imidazopyridines as gastric secretion inhibitors - Google Patents

Polysubstituted imidazopyridines as gastric secretion inhibitors Download PDF

Info

Publication number
SK5072003A3
SK5072003A3 SK507-2003A SK5072003A SK5072003A3 SK 5072003 A3 SK5072003 A3 SK 5072003A3 SK 5072003 A SK5072003 A SK 5072003A SK 5072003 A3 SK5072003 A3 SK 5072003A3
Authority
SK
Slovakia
Prior art keywords
alkoxy
alkyl
hydrogen
halogen
hydroxyl
Prior art date
Application number
SK507-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Jorg Senn-Bilfinger
Wilm Buhr
Wolfgang-Alexander Simon
Stefan Postius
Peter Zimmermann
Wolfgang Kromer
Bernhard Kohl
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SK5072003A3 publication Critical patent/SK5072003A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK507-2003A 2000-10-25 2001-10-23 Polysubstituted imidazopyridines as gastric secretion inhibitors SK5072003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00123133 2000-10-25
PCT/EP2001/012207 WO2002034749A1 (en) 2000-10-25 2001-10-23 Polysubstituted imidazopyridines as gastric secretion inhibitors

Publications (1)

Publication Number Publication Date
SK5072003A3 true SK5072003A3 (en) 2003-09-11

Family

ID=8170193

Family Applications (1)

Application Number Title Priority Date Filing Date
SK507-2003A SK5072003A3 (en) 2000-10-25 2001-10-23 Polysubstituted imidazopyridines as gastric secretion inhibitors

Country Status (19)

Country Link
US (2) US6869949B2 (pt)
EP (1) EP1332143A1 (pt)
JP (1) JP2004512338A (pt)
KR (1) KR20040011423A (pt)
CN (1) CN1692113A (pt)
AU (2) AU2002210563B2 (pt)
BR (1) BR0114873A (pt)
CA (1) CA2426616A1 (pt)
EA (1) EA008151B1 (pt)
HR (1) HRP20030323A2 (pt)
HU (1) HUP0302308A2 (pt)
IL (1) IL154850A0 (pt)
MX (1) MXPA03003706A (pt)
NO (1) NO325736B1 (pt)
NZ (1) NZ525281A (pt)
PL (1) PL360412A1 (pt)
SK (1) SK5072003A3 (pt)
WO (1) WO2002034749A1 (pt)
ZA (1) ZA200302038B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2426616A1 (en) * 2000-10-25 2002-05-02 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
DE10145457A1 (de) * 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
JP2005519933A (ja) 2002-02-15 2005-07-07 アルタナ ファルマ アクチエンゲゼルシャフト 三環式n−アシル化合物
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines
PL375933A1 (en) * 2002-12-20 2005-12-12 Altana Pharma Ag 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
WO2004071391A2 (en) * 2003-02-17 2004-08-26 Altana Pharma Ag Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
CN1764665A (zh) * 2003-04-03 2006-04-26 奥坦纳医药公司 咪唑并吡啶-8-酮的生产方法
AR044129A1 (es) * 2003-05-06 2005-08-24 Altana Pharma Ag Compuestos intermedios de imidazopiridina. proceso de preparacion.
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
WO2005058894A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR046941A1 (es) * 2003-12-19 2006-01-04 Altana Pharma Ag Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico
CA2582256A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
AR051375A1 (es) * 2004-10-15 2007-01-10 Altana Pharma Ag Imidazopiridinas difluoro substituidas
WO2008058990A1 (en) * 2006-11-16 2008-05-22 Nycomed Gmbh 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
WO1992021341A1 (en) * 1991-05-31 1992-12-10 Pfizer Inc. Use of rapamycin prodrugs as immunosuppressant agents
DE4308095A1 (de) * 1993-03-13 1994-09-15 Hoechst Ag Prodrug-Derivate von Arzneimittelwirkstoffen mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
EA002402B1 (ru) * 1997-03-24 2002-04-25 Бык Гульден Ломберг Хемише Фабрик Гмбх Тетрагидропиридо-соединения
ZA982445B (en) * 1997-03-24 1998-09-24 Byk Gulden Lomberg Chem Fab Tetrahydropyrido compounds
CA2289542A1 (en) * 1997-05-28 1998-12-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Fused dihydropyrans
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
PL193616B1 (pl) * 1998-09-23 2007-02-28 Altana Pharma Ag Tetrahydropirydoetery
EP1127059B1 (en) * 1998-11-03 2008-02-20 Nycomed GmbH Imidazonaphthyridines
SI1173439T1 (en) * 1999-04-17 2003-10-31 Altana Pharma Ag Haloalkoxy imidazonaphthyridines
BR0109483A (pt) 2000-03-29 2003-06-10 Altana Pharma Ag Pró-drogas de derivados de imidazopiridina
MXPA02009550A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Derivados de pirano (2,3,c)imidazo(1,2-a]piridina para el tratamiento de trastornos gastrointestinales.
AU783764B2 (en) * 2000-03-29 2005-12-01 Altana Pharma Ag Alkylated imidazopyridine derivatives
ATE356131T1 (de) * 2000-03-29 2007-03-15 Altana Pharma Ag Tricyclische imidazopyridine
CA2426616A1 (en) * 2000-10-25 2002-05-02 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors

Also Published As

Publication number Publication date
EP1332143A1 (en) 2003-08-06
US7141567B2 (en) 2006-11-28
PL360412A1 (en) 2004-09-06
NZ525281A (en) 2004-11-26
US20040214852A1 (en) 2004-10-28
US20040106642A1 (en) 2004-06-03
BR0114873A (pt) 2003-07-01
MXPA03003706A (es) 2005-01-25
ZA200302038B (en) 2004-04-22
US6869949B2 (en) 2005-03-22
EA008151B1 (ru) 2007-04-27
NO20031830D0 (no) 2003-04-24
EA200300478A1 (ru) 2003-12-25
JP2004512338A (ja) 2004-04-22
NO325736B1 (no) 2008-07-14
CN1692113A (zh) 2005-11-02
AU2002210563B2 (en) 2007-03-01
HUP0302308A2 (hu) 2003-11-28
NO20031830L (no) 2003-04-24
AU1056302A (en) 2002-05-06
HRP20030323A2 (hr) 2005-04-30
IL154850A0 (en) 2003-10-31
CA2426616A1 (en) 2002-05-02
WO2002034749A1 (en) 2002-05-02
KR20040011423A (ko) 2004-02-05

Similar Documents

Publication Publication Date Title
AU2002210563B2 (en) Polysubstituted imidazopyridines as gastric secretion inhibitors
AU2002210563A1 (en) Polysubstituted imidazopyridines as gastric secretion inhibitors
SK13872002A3 (sk) Alkylové imidazopyridínové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
KR20070009614A (ko) 7h-8,9-디히드로-피라노(2,3-c)이미다조(1,2-a)피리딘유도체 및 이의 위산 분비 억제제로서의 용도
CA2582294A1 (en) Condensed tricyclic benzimidazoles for the treatment of gastrointestinal disorders
US20060035892A1 (en) Nitrosated imidazopyridines
US20040235883A1 (en) Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
US20040235882A1 (en) Amino-substituted imidazopyridines for the treatment of gastrointestial diseases
EP1797089A1 (en) Substituted tricyclic benzimidazoles
US20070244173A1 (en) 6,7-Dihydroxy-8-Phenyl-3,6,7,8-Tetrahydro-Chromeno [7,8-d] Imidazole Derivatives and Their Use as Gastric Acid Secretion Inhibitors
EP1718648B1 (en) Tricyclic imidazopyridines and intermediates for the synthesis thereof
AU2002328995A1 (en) Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders

Legal Events

Date Code Title Description
FC9A Refused patent application